Burden of Chemotherapy Induced Febrile Neutropenia and Role of G-CSF in Febrile Neutropenia in a Low-Income Country: The Children's Hospital Lahore Pakistan Experience

被引：0
|
作者：
Ahmad, A. [1 ,2 ]
Khan, F. S. [3 ,4 ]
Sadiq, M. [3 ,5 ]
机构：
[1] Children Hosp, Lahore, Pakistan
[2] Inst Child Hlth Lahore, Paediat Haematol Oncol, Lahore, Pakistan
[3] Childrens Hosp, Lahore, Pakistan
[4] Inst Child Hlth Lahore Pakistan, Paediat Haematol, Lahore, Pakistan
[5] Inst Child Hlth Lahore Pakistan, Lahore, Pakistan
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-052
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [21] A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia
    Y. Lalami
    M. Paesmans
    M. Aoun
    R. Munoz-Bermeo
    K. Reuss
    S. Cherifi
    C. G. Alexopoulos
    J. Klastersky
    Supportive Care in Cancer, 2004, 12 : 725 - 730
  • [22] G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review
    Campbell, Kim
    Chadha, Nidhi
    Dimri, Seema
    Wang, Weijia
    Li, Edward
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (07) : 619 - 633
  • [23] Febrile neutropenia does not affect collection of adequate CD34+ cells after mobilization with chemotherapy and G-CSF
    Yee, K
    Tu, JV
    MacKinnon, J
    Gandhi, M
    Stewart, AK
    Saragosa, R
    Keating, A
    Crump, M
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 310 - 310
  • [24] Randomized comparison of antibiotics alone and with granulocyte colony-stimulating factor (G-CSF) in children with chemotherapy-induced febrile neutropenia: A report from the Children's Oncology Group
    Ozkaynak, MF
    Krailo, M
    Chen, N
    Feusner, J
    PEDIATRIC RESEARCH, 2004, 55 (04) : 311A - 311A
  • [25] Prophylactic G-CSF and GM-CSF decrease febrile neutropenia following chemotherapy in children with cancer: A meta-analysis of randomized controlled trials.
    Sung, L
    Nathan, PC
    Lange, B
    Beyene, J
    Buchanan, G
    BLOOD, 2003, 102 (11) : 251A - 251A
  • [26] G-CSF prophylaxis of febrile neutropenia and infections after chemotherapy [G-CSF-Prophylaxe von febriler Neutropenie und Infektionen nach Chemotherapie]
    Link H.
    Der Onkologe, 2014, 20 (3): : 268 - 270
  • [27] USE OF G-CSF PROPHYLAXIS AND INCIDENCE OF FEBRILE NEUTROPENIA AMONG MEDICARE BENEFICIARIES RECEIVING CHEMOTHERAPY IN TRADITIONAL AND ALTERNATIVE PAYMENT MODELS
    Hanau, A.
    Weycker, D.
    Lonshteyn, A.
    Shah, N.
    Lawrence, T.
    Hatfield, M.
    VALUE IN HEALTH, 2020, 23 : S50 - S50
  • [28] Association between febrile neutropenia and use of G-CSF in chemotherapy of extensive-disease small-cell lung cancer
    Fujiwara, Takumi
    Taira, Tetsuhiko
    Wakuda, Kazushige
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naitou, Tateaki
    Murakami, Haruyasu
    Mori, Keita
    Endou, Masahiro
    Takahashi, Toshiaki
    ANNALS OF ONCOLOGY, 2015, 26 : 93 - 94
  • [29] Consensus survey on the management of children with chemotherapy-induced febrile neutropenia and at low risk of severe infection
    Givone, Aude
    Duval-Destin, Jean
    Delebarre, Mathilde
    Abou-Chahla, Wadih
    Lervat, Cyril
    Dubos, Francois
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2024, 41 (02) : 172 - 178
  • [30] Characterization of bacteremia and healthcare cost burden in ALL patients admitted with febrile neutropenia at a children's hospital.
    Eldridge, Brenna
    Knackstedt, Elizabeth D.
    Korgenski, E. Kent
    Stockmann, Chris
    Raetz, Elizabeth A.
    Lemons, Richard S.
    Schiffman, Joshua David
    Blaschke, Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345